What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy

This article proposes a potential link between androgenetic alopecia and COVID-19 severity. The authors suggest that studying the epidemiology of COVID-19 patients with predispositions to either lower or higher androgen receptor expression could provide insight into the role of AR in the severity of COVID-19 infection. The activation of AR can be reduced by several classes of drugs, including androgen receptor antagonists, androgen synthesis inhibitors, and antigonadotropins, which could be studied as potential therapies for COVID-19.